PHARMACYTE BIOTECH INC (PMCB) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:PMCB • US71715X2036

0.7412 USD
+0.04 (+5.89%)
At close: Feb 6, 2026
0.8 USD
+0.06 (+7.93%)
After Hours: 2/6/2026, 8:00:50 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to PMCB. The Buy consensus is the weighted average rating of the current analysts ratings.

  • PMCB was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PMCB.
  • In the previous month the buy percentage consensus was at a similar level.
  • PMCB was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
PMCB Historical Analyst RatingsPMCB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5
PMCB Current Analyst RatingPMCB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2021-11-08 HC Wainwright & Co. Initiate Neutral

PHARMACYTE BIOTECH INC / PMCB FAQ

Can you provide the consensus rating for PHARMACYTE BIOTECH INC stock?

The consensus rating for PHARMACYTE BIOTECH INC (PMCB) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


What is the number of analysts for PMCB stock?

The number of analysts covering PHARMACYTE BIOTECH INC (PMCB) is 6.